- Home
- LNTH vs CVCO Comparison
LNTH vs CVCO Comparison
Compare LNTH & CVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- CVCO
- Stock Information
- Founded
- LNTH 1956
- CVCO 1965
- Country
- LNTH United States
- CVCO United States
- Employees
- LNTH N/A
- CVCO N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CVCO Homebuilding
- Sector
- LNTH Health Care
- CVCO Consumer Discretionary
- Exchange
- LNTH Nasdaq
- CVCO Nasdaq
- Market Cap
- LNTH 3.8B
- CVCO 4.3B
- IPO Year
- LNTH 2015
- CVCO N/A
- Fundamental
- Price
- LNTH $53.45
- CVCO $550.17
- Analyst Decision
- LNTH Buy
- CVCO Hold
- Analyst Count
- LNTH 6
- CVCO 1
- Target Price
- LNTH $74.17
- CVCO $550.00
- AVG Volume (30 Days)
- LNTH 1.3M
- CVCO 140.2K
- Earning Date
- LNTH 11-06-2025
- CVCO 10-30-2025
- Dividend Yield
- LNTH N/A
- CVCO N/A
- EPS Growth
- LNTH N/A
- CVCO 37.54
- EPS
- LNTH 2.39
- CVCO 24.29
- Revenue
- LNTH $1,525,933,000.00
- CVCO $2,143,782,000.00
- Revenue This Year
- LNTH N/A
- CVCO $14.76
- Revenue Next Year
- LNTH $1.98
- CVCO $8.04
- P/E Ratio
- LNTH $22.20
- CVCO $22.80
- Revenue Growth
- LNTH 1.95
- CVCO 15.76
- 52 Week Low
- LNTH $47.25
- CVCO $393.53
- 52 Week High
- LNTH $111.29
- CVCO $602.57
- Technical
- Relative Strength Index (RSI)
- LNTH 45.58
- CVCO 50.30
- Support Level
- LNTH $50.16
- CVCO $491.29
- Resistance Level
- LNTH $55.55
- CVCO $586.34
- Average True Range (ATR)
- LNTH 2.71
- CVCO 29.28
- MACD
- LNTH -0.41
- CVCO 0.46
- Stochastic Oscillator
- LNTH 28.09
- CVCO 57.09
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About CVCO Cavco Industries Inc. When Issued
Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.